XPAR
BLC
Market cap194mUSD
Jul 09, Last price
23.30EUR
1D
-1.89%
1Q
-6.99%
Jan 2017
-1.89%
Name
Bastide le Confort Medical SA
Chart & Performance
P/E
322.52
P/S
0.35
EPS
0.07
Div Yield, %
—
Shrs. gr., 5y
1.54%
Rev. gr., 5y
5.12%
Revenues
491m
-7.28%
Net income
528k
P
CFO
72m
+8.83%
Dividend
Jan 07, 20220.27 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bastide Le Confort Médical S.A. is a French enterprise engaged in both the sale and rental of an extensive array of medical equipment. Its comprehensive product portfolio caters to various needs, including personal comfort and daily living aids such as lift chairs, specialized pillows, bathroom and well-being products, technical assistance devices, and health monitoring equipment like blood pressure monitors and pill organizers. The company also offers a full line of incontinence management solutions, encompassing absorbent briefs, protective pads for both genders, disposable mattress covers, and essential hygiene items. For home support and enhanced mobility, their inventory includes wheelchairs, electric scooters, walkers, adjustable bed tables, patient lifts, and standing aids. Furthermore, Bastide Le Confort Médical supplies various medical consumables, including dressings, hygiene and disinfection products, and professional medical attire. Beyond its product offerings, the company provides vital home assistance services specifically designed for elderly individuals, seniors, and those with disabilities. Customers can acquire these products and services through a network of approximately 130 physical retail locations across France, as well as through its dedicated online store. Founded in 1977, Bastide Le Confort Médical S.A. is headquartered in Caissargues, France.
IPO date
May 15, 1997
Employees
3,375
Domiciled in
FR
Incorporated in
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||